Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics

Journal of Clinical Psychiatry

Volumn 62, Issue 11, 2001, Pages 843-848

  Hagg S ^a   Soderberg S ^a   Ahren B ^a   Olsson, T ^a   Mjorndal T ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEPTIN; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; FEMALE; HUMAN; HYPERLIPIDEMIA; INJECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PSYCHOPHARMACOLOGY; PSYCHOSIS; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 0035197130     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1102     Document Type: Article

References (43)

1. Weight gain associated with psychotropic drugs
2. Weight gain associated with neuroleptic medication: A review
3. Weight gain among schizophrenic patients treated with clozapine
4. Clozapine-induced weight gain: Prevalence and clinical relevance
5. Olanzapine-induced weight gain
6. Novel antipsychotics: Comparison of weight gain liabilities
7. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
8. Clozapine and associated diabetes mellitus
9. Novel antipsychotics and new onset diabetes
10. Olanzapine-induced glucose dysregulation
11. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses
12. Clozapine-associated elevation in serum triglycerides
13. Olanzapine increases weight and serum triglyceride levels
14. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
15. Definition, diagnosis and classification of diabetes mellitus and its complications, pt 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
16. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
17. Is leptin the link between obesity and insulin resistance?
18. Sympathetic and cardiorenal actions of leptin
19. Serum leptin levels increase rapidly after initiation of clozapine therapy
20. Body weight and leptin plasma levels during treatment with antipsychotic drugs
21. Regulation of circulating leptin in humans
22. Pharmacokinetic optimisation of the treatment of psychosis
23. Comparative doses and costs of antipsychotic medication
24. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
25. Antipsychotic drug-induced obesity in rats: Correlation between leptin, insulin and body weight during sulpiride treatment
26. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men
27. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity
28. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
29. 2C serotonin receptors
30. 2C receptor gene
31. In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug
32. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice
33. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine
34. Involvement of the histaminergic system in leptin-induced suppression of food intake
35. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus
36. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells
37. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross sectional study
38. Serum immunoreactiveleptin concentrations in normal-weight and obese humans
39. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
40. Leptin concentrations and insulin sensitivity in normoglycemic men
41. Entrainment of the diurnal rhythm of plasma leptin to meal timing